None
Quote | Alligator Bioscience AB (OTCMKTS:ALLGF)
Last: | $ |
---|---|
Change Percent: | 0.00% |
Open: | $N/A |
Close: | $2.9604 |
High: | $N/A |
Low: | $N/A |
Volume: | 0 |
Last Trade Date Time: | 01/09/2020 04:33:02 pm |
News | Alligator Bioscience AB (OTCMKTS:ALLGF)
MacroGenics (MGNX) and Alligator Bioscience (ALLGF) have collaborated to expand latter's proprietary patient specific immunotherapy Neo-X-Prime with MGNX's DART and TRIDENT multi-specific platforms against two undisclosed targets. Under the collaboration, which covers activities fro...
Alligator Bioscience (ALLGF) appointed Dr. Christina Reimer as Chief Medical Officer. Most recently, she held a position as Senior Medical Director at Ferring Pharmaceuticals in Copenhagen.Dr. Reimer will replace Dr. Charlotte Russel and be overall medically resp...
Message Board Posts | Alligator Bioscience AB (OTCMKTS:ALLGF)
Subject | By | Source | When |
---|---|---|---|
No posts yet. |
News, Short Squeeze, Breakout and More Instantly...
Alligator Bioscience AB Company Name:
ALLGF Stock Symbol:
OTCMKTS Market:
Alligator Bioscience recruits new Chief Medical Officer PR Newswire LUND, Sweden , Dec. 29, 2020 /PRNewswire/ -- Alligator Bioscience (Nasdaq Stockholm: ATORX) today announced that the company has appointed Dr Christina Reimer as Chief Medical Officer. Sh...
Alligator Bioscience submits CTA for the mitazalimab Phase II study OPTIMIZE-1 PR Newswire LUND, Sweden , Dec. 28, 2020 /PRNewswire/ -- Alligator Bioscience (Nasdaq Stockholm: ATORX) today announced that it has submitted a CTA (Clinical Trial Authorization) a...
Alligator Bioscience launches ALLIGATOR-FAB™ - a novel human antibody library LUND, Sweden , Dec. 10, 2020 /PRNewswire/ -- Alligator Bioscience (Nasdaq Stockholm: ATORX) today announced the completion of a novel proprietary human synthetic antibody librar...